In vivo but not in vitro stimulations rescue of the defective class switching to IgG or IgA in B-cells of immunodeficiency with hyper IgM

Clinical Immunology and Immunopathology

Volumn 83, Issue 3, 1997, Pages 287-292

  Saiki, Osamu ^a   Uda, Hiroshi ^a   Hayashi, Masatoshi ^b   Tanaka, Toshio ^c   Katada, Yoshinori ^c   Shimizu, Masatoshi ^a   Kinoshita, Naokazu ^a   Kishimoto, Tadamitsu ^c  

^a MINAMI OSAKA GENERAL HOSPITAL   (Japan)

^b EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CHILD; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; GENE MUTATION; GENE SWITCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE DEFICIENCY; IMMUNOREGULATION; IMMUNOSTIMULATION; MALE; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; X CHROMOSOME LINKAGE;

EID: 0031172134     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4349     Document Type: Article

References (29)

1. Notarangero L. D., Duse M., Ugazio A. G. Immunodeficiency with hyper IgM. Immunodeficiency Revi. 3:1992;101-122.
2. Schwaber J., Rosen F. S. X chromosome linked immunodeficiency. Immunodeficiency Rev. 2:1990;233-251.
3. Puck J. M. X-Linked Immunodeficiencies: Advances in Human Genetics. 1993;Plenum, New York. p. 107-144.
4. Clark E. A., Ledbetter J. A. Activation of human B cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc. Natl. Acad. Sci. USA. 83:1986;4494-4498.
5. Stamenkovic I., Clark E. A., Seed B. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas. EMBO J. 8:1989;1403-1410.
6. Graf D., Korthauer U., Mages H. W., Senger G., Kroczer R. A. Cloning of TRAP, a ligand for CD40 on human T cells. Eur. J. Immunol. 22:1992;3191-3194.
7. Armitage R. J., Macduff B. M., Spriggs M. K., Fanslow C. Human B cell proliferation and Ig secretion induced by recombinant CD40 ligand are modulated by soluble cytokines. J Immunol. 150:1993;3671-3680.
8. Banchereau J., de Paoli P., Valle A., Garcia E., Rousset F. Long term human B cell lines dependent on interleukin-4 and antibody to CD40. Science. 251:1991;70-72.
9. Armitage R. J., Fanslow W. C., Strockbine L., Sato T. A., Clifford K. N., Macduff B. M., Anderson D. M., Gimpel S. D., Davis Smith T., Maliszewski C. R., Clark E. A., Smith C. A., Grabstein K. H., Cosman D., Spriggs M. K. Molecular and biological characterization of a murine ligand for CD40. Nature. 357:1992;80-82.
10. Hollenbaugh D., Grosmaire L. S., Kullas C. D., Chalupny N. J., Braesch-Andersen S., Noelle R. J., Stamenkovic I., Ledbetter J. A., Aruffo A. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form gp39 with B cell costimulatory activity. EMBO J. 11:1992;4313-4321.
11. Allen R. C., Armitage R. J., Conley M. E., Rosenblatte H., Jenkins N. A., Copeland N. G., Bedell M. A., Edelhoff S., Disteche C. M., Simoneaux D. K., Fanslow W. C., Belmont J., Spriggs M. K. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science. 259:1993;990-993.
12. Aruffo A., Farrington M., Hollenbaugh D., Li X., Milatovich A., Nonoyama S., Bajorath J., Grosmaire L. S., Stenkamp R., Neubauer M., Roberts R. L., Noelle R. J., Ledbetter J. A., Francke U., Ochs H. D. The CD40L ligand, gp39, is defective in activated T cells from patients with X- linked hyper-IgM syndrome. Cell. 72:1993;291-300.
13. Korthauer U., Graf D., Mages H. W., Briere F., Padayachee M., Malcom S., Ugazio A. G., Notarangelo L. D., Levinsky R. J., Kroczek R. A. Defective expression of T cell CD40 ligand causes X-linked Immunodefeciency with hyper-IgM. Nature. 361:1993;539-541.
14. Fuleihan R., Ramesh N., Loh R., Jabara H., Rosen R. S., Chatila T., Fu S. M., Stamenkovic I., Geha R. S. Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc. Natl. Acad. Sci. USA. 90:1993;2170-2173.
15. Durandy A., Suhiff C., Bonnefoy J., Forveille M., Rousset F., Mazzei G., Milili M., Fischer A. Induction by anti-CD40 or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B cells from patients with X-linked hyper IgM syndrome. Eur. J. Immunol. 23:1993;2294-2299.
16. Saiki O., Tanaka T., Wada Y., Uda H., Inoue A., Katada Y., Izeki M., Iwata M., Nunoi H., Matsuda I., Kinoshita N., Kishimoto T. Signaling through CD40 rescues IgE but not IgG or IgA secretion in X-linked immunodeficiency with hyper-IgM. J. Clin. Invest. 95:1995;510-514.
17. Mosier D. E., Gulizia R. J., Baird S. M., Wilson D. B. Transfer of a functional human immune system to mice with severe combined immunodeficiency. Nature. 335:1988;256-259.
18. Saxon A., Macy E., Denis K., Lehmann M. T., Witte O., Braun J. Limited B cell repertoire in severe combined immunodeficient mice engrafted with peripheral blood mononuclear cells derived from immunodeficient or normal humans. J. Clin. Invest. 87:1991;658-665.
19. Chen F. A., Williams S. S., Fanslow W. C., Bankert R. B. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand. J. Immunol. 155:1995;2833-2840.
20. Abedi M. R., Christensson B., Islam K. B., Hammarstrom L., Smith C. I. E. Immunoglobulin production in severe combined immunodeficient (SCID) mice reconstituted with human peripheral blood mononuclear cells. Eur. J. Immunol. 22:1992;823-828.
21. Saiki O., Kawamoto M., Fukuzumi M., Kanou M., Utsumi S. Staphylococcus aureus Wood 46 strain activates human B cell without affecting DNA synthesis or tyrosine phosphorylation. J. Immunol. 150:1993;3324-3229.
22. Banchereau J., Paoli P. D., Valle A., Garcia E., Rousset F. Long-term human B cell lines dependent on Interleukin-4 and antibody to CD40. Science. 251:1991;70-72.
23. Saiki O., Ralph P., Cunningham-Rundles C., Good R. A. Three distinct stages of B-cell defects in common variable immunodeficiency. Proc. Natl. Acad. Sci. USA. 79:1982;6008-6012.
24. Hendriks R. W., Kraakman M. E. M., Craig I. W., Espanol T., Schuurman R. K. B. Evidence that in X-linked immnodeficiency with hyper-immunoglobulinemia M the intrinsic immunoglobulin heavy chain class switch mechanism is intact. Eur. J. Immunol. 20:1990;2603-2608.
25. Saiki O., Ralph P. IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells. Eur. J. Immunol. 12:1982;506-510.
26. Rousset F., Garcia E., Defrance T., Peronne C., Vezzio N., Hsu D. H., Kastelein R., Moore K. W., Banchereau J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. J. Immunol. 89:1992;1890-1893.
27. Spriggs M. K., Armitage R. J., Strockbine L., Clifford K. N., Macduff B. M., T.A. Sato C.R. Maliszewski, and Fanslow, W. C., Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. Exp. Med. 176:1992;1543-1550.
28. Shapira S. K., Vercelli D., Jabara H., Fu S. M., Geha R. S. Molecula analysis of the induction of immunoglobulin E synthesis in human B cells by interleukin 4 and engagement of CD40 antigen. J. Exp. Med. 175:1992;289-292.
29. Defrance T., Vanbervliet B., Briere F., Durand I., Rousset F., Banchereau J. Interleukin 10 and transforming growth factor β cooperate to induce anti-CD40-activated naive human B cells to secrete immunoglobulin A. J. Exp. Med. 175:1992;671-682.